Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Monopar Therapeutics Inc MNPR

Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for cancer patients. The Company is building a drug candidate pipeline through in-house development as well as the licensing and acquisition of therapeutics in late preclinical and in clinical development stages. The Company has several compounds in development, which include MNPR-101-Zr... see more

NDAQ:MNPR - Post Discussion

Monopar Therapeutics Inc > Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | Benz
View:
Post by whytestocks on Feb 22, 2024 12:30pm

Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | Benz

NEWS: $MNPR Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | BenzingaU.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday.The Dow traded up 0.67% to 38,87...MNPR - Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 | Benzinga
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities